Evaxion Biotech A/S (EVAX) Earnings Date, Estimates & Call Transcripts $1.68 -0.08 (-4.55%) (As of 11/14/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evaxion Biotech A/S Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 26EstimatedActual EPS (Oct. 31) -$0.04 Beat By $0.08 Consensus EPS (Oct. 31) -$0.12 Evaxion Biotech A/S issued Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.04, which topped the consensus estimate of -$0.12 by $0.08. Quarterly revenue was reported to be $3.02 million, above analysts' expectations of $0.19 million. With a trailing EPS of -$0.29, Evaxion Biotech A/S's earnings are expected to grow next year, from ($0.15) to ($0.11) per share. Conference Call TranscriptEVAX Upcoming EarningsEvaxion Biotech A/S's next earnings date is estimated for Wednesday, March 26, 2025, based off prior year's reporting schedules. Get Evaxion Biotech A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evaxion Biotech A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EVAX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Evaxion Biotech A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241$0.02$0.02$0.02Q3 20241-$0.12-$0.12-$0.12Q4 20241-$0.12-$0.12-$0.1220243-$0.22-$0.22-$0.22Q1 20251-$0.12-$0.12-$0.12Q2 20251-$0.12-$0.12-$0.12Q3 20251-$0.13-$0.13-$0.13Q4 20251-$0.10-$0.10-$0.10FY 20254-$0.47-$0.47-$0.47Q1 20261-$0.10-$0.10-$0.10Q2 20261-$0.11-$0.11-$0.11 Evaxion Biotech A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/26/2025(Estimated)------- 10/31/2024Q3 2024-$0.12-$0.04+$0.08-$0.04$0.19M$3.02M 8/14/2024Q2 2024$0.02-$0.12 -$0.14-$0.12$0.10M$0.15M 5/28/2024Q1 2024-$0.03+$0.03$0.03-$0.05M3/27/2024Q4 2023--$0.16 -$0.16-$0.16-$0.07M12/19/2023Q3 2023-$1.90-$2.10 -$0.20-$0.21-- 8/22/2023Q2 2023-$2.20-$2.10+$0.10-$0.21-- Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 5/31/2023Q1 2023-$2.60-$2.40+$0.20-$0.24-- 4/27/2023Q4 2022--$2.90 -$2.90-$0.29--11/14/2022Q3 2022-$3.40-$2.40+$1.00-$0.24-- Evaxion Biotech A/S Earnings - Frequently Asked Questions When is Evaxion Biotech A/S's earnings date? Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates. Learn more on EVAX's earnings history. Did Evaxion Biotech A/S beat their earnings estimates last quarter? In the previous quarter, Evaxion Biotech A/S (NASDAQ:EVAX) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.08. Learn more on analysts' earnings estimate vs. EVAX's actual earnings. How can I read Evaxion Biotech A/S's conference call transcript? The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online. Read Transcript How much revenue does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded annual revenue of $70,000.00. How much profit does Evaxion Biotech A/S generate each year? Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded net income of -$22.12 million. EVAX has generated -$0.29 earnings per share over the last four quarters. What is Evaxion Biotech A/S's EPS forecast for next year? Evaxion Biotech A/S's earnings are expected to grow from ($0.15) per share to ($0.11) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Atara Biotherapeutics Earnings Protara Therapeutics Earnings CEL-SCI Earnings Achilles Therapeutics Earnings Elevation Oncology Earnings Passage Bio Earnings Dyadic International Earnings Surrozen Earnings Aligos Therapeutics Earnings SAB Biotherapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. This page (NASDAQ:EVAX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
